« Previous | Contents | Next »
Listen
Consultation: Particular Questions
1) Common principles for healthcare
1. What role (if any) should the Commission have in setting standards for cross-border healthcare?
2) Use of healthcare in another Member State
2. Could there be clinical grounds on which healthcare commissioners should be able to refuse to authorise NHS patients going to another EU Member State?
3. How can the UK Government and devolved administrations ensure that these proposals do not adversely affect the NHS ability to plan and manage services (including the ability to retain appropriate 'Gatekeeping' arrangements)? Should prior authorisation schemes be the norm rather than the exception?
4. Do you believe the Commission or Member States are best placed to set the list of treatments that are included in the definition of 'hospital care'?
5. How can the NHS ensure that patients coming from other Member States are treated in a non-discriminatory fashion that protects clinical prioritisation and does not lead to a detrimental effect on UK patients?
6. Comments are invited on the likely volume of patients who may wish to access cross-border health care and the treatments they may wish to obtain, in a context of prior authorisation for hospital care.
7. What information, and presented in what format(s), do you think patients need to make an informed decision on receiving treatment in another EU Member State?
8. Where should NHS national contact points be located, should they only be required to provide information about patient rights/entitlements and the home system and how might they make use of existing resources?
3) Co-operation on healthcare
9. Is an EU prescription template feasible and what would it look like? What advantages and disadvantages could there be to this?
10. How do you think the European Reference Networks and proposed Health Technology Assessment Network might best add value to the UK?
11. The draft Directive proposes that the EU plays a greater role in setting required standards in data collection and eHealth (including health record, systems and ePrescriptions). Would this add value and what impact might this have on current UK systems?
Other questions on the impact of the draft Directive
12. What are the implications of this draft Directive for private insurance schemes and private providers?
13. What proportionate measures can we take to ensure that all patients, regardless of age, race or ethnicity, disability, religion or belief, gender, sexual orientation or socio-economic status feel a) reassured they will be treated with respect and their specific needs considered b) they are fully informed to make the right choice for them?
14. To what extent do you think that these proposals will have a positive or an adverse impact on equity? What can be done to manage any adverse impact?
« Previous | Contents | Next »